4-(1-adamantyl)-3-thiosemicarbazones as potential chemotherapeutic agents.
D000818:Animals; D002279:Carcinoma 256, Walker / Q000188:drug therapy*; D003454:Cryptococcus / Q000187:drug effects*; D003516:Cycloparaffins; D006658:Histoplasma / Q000187:drug effects*; D007939:Leukemia L1210 / Q000188:drug therapy*; D008288:Malaria / Q000188:drug therapy*; D051379:Mice; D013882:Thiosemicarbazones / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity
D003516:Cycloparaffins; D013882:Thiosemicarbazones